Save
esh.org
NO
ESH eLearning, Fredrik Schjesvold, 336519
Discussion
ESH eLearning, Faculty / Presenters, 336520
Interactive case: Relapsed multiple myeloma
ESH eLearning, Xavier Leleu, 336512
Case-based lecture : How I treat first relapse
ESH eLearning, Paula Rodríguez-Otero, 336513
Case-based lecture : How I treat later relapses
ESH eLearning, Stefan Knop, 336514
Case-based lecture : Novel agents in relapsed multiple myeloma
ESH eLearning, Enrique Ocio, 336515
Brief Oral Communication -Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) X CD3 Bispecific Antibody, in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM): Results from an Ongoing Phase 1 Study
ESH eLearning, Faculty / Presenters, 336516
Brief Oral Communication - HORIZON (OP-106): Melflufen Plus Dexamethasone in 55 Patients with Relapsed/Refractory Multiple Myeloma (RRMM) with Extramedullary Disease (EMD)—Subgroup Analysis
ESH eLearning, PAUL RICHARDSON, 336517
YES
ESH eLearning, Salomon Manier, 336509
NO
ESH eLearning, Ola Landgren, 336510
Discussion
ESH eLearning, Faculty / Presenters, 336511
YES
ESH eLearning, Nikhil Munshi, 336506
NO
ESH eLearning, Angela Dispenzieri, 336507
Discussion
ESH eLearning, Faculty / Presenters, 336508
Interactive case: How I treat a high risk patient
ESH eLearning, Faith Davies, 336502
Case-based lecture : NGS guided targeted and immune therapies in multiple myeloma
ESH eLearning, SAMIR PAREKH, 336503
Case-based lecture : My DRUG - precision interception in multiple myeloma
ESH eLearning, Daniel Auclair, 336504
Panel discussion
ESH eLearning, Faculty / Presenters, 336505
ESH eLearning, Faculty / Presenters, 336501
Interactive case: Newly diagnosed transplant eligible multiple myeloma
ESH eLearning, KARTHIK Ramasamy, 336496
Case-based lecture : Tandem transplant in the Dara-era?
ESH eLearning, Charlotte Pawlyn, 336497
Case-based lecture: Are all frail patients frail?
ESH eLearning, Sonja Zweegman, 336498
Brief Oral Communication - Daratumumab Plus Lenalidomide, Bortezomib, and Dexamethasone in Patients with Transplant-Eligible Newly Diagnosed Multiple Myeloma: Updated Analysis of Griffin after 12 Months of Maintenance Therapy
ESH eLearning, Faculty / Presenters, 336499
Panel discussion
ESH eLearning, Faculty / Presenters, 336500
Interactive case: Smoldering myeloma
ESH eLearning, María-Victoria Mateos, 336490
Case-based lecture: Understanding genomics of SMM
ESH eLearning, Irene Ghobrial, 336491
Case-based lecture: Understanding the immune ME of SMM
ESH eLearning, Madhav Dhodapkar, 336492
Case-based lecture: Imaging with PET-CT in SMM
ESH eLearning, Cristina Nanni, 336493
Brief Oral Communication: Early Diagnosis of Multiple Myeloma By Means of a Computer-Aided Algorithm.
ESH eLearning, Faculty / Presenters, 336494
Panel discussion
ESH eLearning, Faculty / Presenters, 336495
Panel Discussion
ESH eLearning, Faculty / Presenters, 348350
Inclusion of a shRNA Targeting BCL11A into a β-Globin Expressing Vector Allows Concurrent Synthesis of Curative Adult and Fetal Hemoglobin
ESH eLearning, Danuta Jarocha, 348349
New approcahes for managing SCD
ESH eLearning, Lucia De Franceschi, 348348
New approaches to anemia of MDS
ESH eLearning, Uwe Platzbecker, 348347
Iron restrictided erythropoiesis
ESH eLearning, Tomas Ganz, 348346
Panel Discussion
ESH eLearning, Faculty / Presenters, 348345
Focus on: Immunotherapy and CAR-T in MDS: Dream or reality ?
ESH eLearning, Rafael Bejar, 348344
Gene therapy in hemoglobinophaties vs gene editing
ESH eLearning, Mitchell J. Weiss, 348343
Who is the best patient candidate to gene therapy ?
ESH eLearning, Vip Viprakasit, 348342
Panel Discussion
ESH eLearning, Faculty / Presenters, 348341
Haploidentical Stem Cell Tran​splantation for High Risk Haemoglobinopathies Using Post-Transplant Cyclophosphamide
ESH eLearning, Du'A Darabsheh, 348340
DBA
ESH eLearning, Lydie Da, 348339
Panel Discussion
ESH eLearning, Faculty / Presenters, 348338
Atypical microcytic anemias
ESH eLearning, Graça Porto, 348337
Macrophage and iron
ESH eLearning, Martina Muckenthaler, 348336
Panel Discussion
ESH eLearning, Faculty / Presenters, 348335
BM 3D modelling
ESH eLearning, Alessandra Balduini, 348334
Eryptosis
ESH eLearning, Faculty / Presenters, 348333
Erythroid progenitors though.
ESH eLearning, Lionel Blanc, 348332
Panel Discussion
ESH eLearning, Faculty / Presenters, 348331
Acquired α-Thalassemia (HbH disease) in a Patient with Myelodysplastic Syndrome with Excess Blasts - 1 (AT-MDS-EB-1) Reveals a Novel Splice-Donor Site Atrx variant on NGS
ESH eLearning, Prashant Sharma, 348330
Congenital sideroblastic anemias
ESH eLearning, Mark Fleming, 348329
Panel Discussion
ESH eLearning, Faculty / Presenters, 348328
Why is the translation selectivity of low ribosome availability deleterious for erythropoiesis?
ESH eLearning, ismael boussaid, 348327
Into the mechanisms of dyserythopoiesis: the SF3B1 mutation and RSP-14 deficiency models
ESH eLearning, Michaela Fontenay, 348326
Panel Discussion
ESH eLearning, Faculty / Presenters, 348325
Hematopoiesis in MDS and Covid 19 infection
ESH eLearning, Eric Solary, 348324
Focus on : Blood management during COVID outbreak
ESH eLearning, Giancarlo Liumbruno, 348323
Iron and viral infection
ESH eLearning, Alexander Drakesmith, 348322
Panel Discussion
ESH eLearning, Faculty / Presenters, 348321
Targeting TFR2: A Novel “Erythropoiesis-Stimulating” Approach​
ESH eLearning, Antonella Nai, 348320
Panel discussion
ESH eLearning, Faculty / Presenters, 348318
Brief oral Communication: The CRISPR/Cas9 system abolishes the tumorigenic ability of BCR/ABL and restoring the normal haematopoiesis in the bone marrow niche of NOD/SCID mice
ESH eLearning, Elena Vuelta Ramos, 348317
Interactive case: Blastic plasmacytoid dendritic cell neoplasms
ESH eLearning, Naveen Pemmaraju, 348316
Interactive case: Treatment-free remission strategy in CP CML in 2021
ESH eLearning, Franck Emmanuel Nicolini, 348315
Case-based lecture: Interferon alpha
ESH eLearning, Andreas Buchert, 348314
Case-based lecture: New technologies in monitoring
ESH eLearning, Nick CROSS, 348313
Interactive case: Prognostic factors for successful TFR
ESH eLearning, Susanne Saussele, 348312
Panel discussion
ESH eLearning, Faculty / Presenters, 348311
Brief oral Communication: Cpi-0610, a bromodomain and extraterminal domain protein (BET) inhibitor, in combination with ruxolitinib, in JAK-Inhibitor-Naïve Myelofibrosis patients: update of manifest Phase 2 study
ESH eLearning, Francesco Passamonti, 348310
Interactive case: Venetoclax data
ESH eLearning, Srdan Verstovsek, 348309
Interactive case: CMML
ESH eLearning, Donal McLornan, 348308
Case-based lecture: Blast crisis in CML
ESH eLearning, Dragana Milojkovic, 348307
Case-based lecture: Management of rare translocations MPN entities FGFR1 and JAK2 partner geners
ESH eLearning, Andreas Reiter, 348305
Panel discussion
ESH eLearning, Faculty / Presenters, 348304
Brief oral Communication: Genomic analysis of primary and secondary Myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study
ESH eLearning, Damien Luque Paz, 348303
Interactive case: When to switch from Ruxolitinib
ESH eLearning, Haifa Kathrin Al-Ali, 348302
Case-based lecture: Evolving therapies for myelofibrosis; non-JAK inhibitor approaches
ESH eLearning, John Mascarenhas, 348301
Case-based lecture: JAK inhibitors in combination
ESH eLearning, Srdan Verstovsek, 348300
Case-based lecture: Other JAK inhibitors (Momelotinib, Pacritinib)
ESH eLearning, Adam Mead, 348299
Interactive case: Therapy of Myelofibrosis with approved agents
ESH eLearning, Ruben Mesa, 348298
Discussion
ESH eLearning, Faculty / Presenters, 348297
No
ESH eLearning, Delphine Rea, 348296
Yes
ESH eLearning, Jane APPERLEY, 348295
Introduction
ESH eLearning, Andreas Hochhaus, 348294
Discussion
ESH eLearning, Faculty / Presenters, 348293
Interferon alpha in pregnancies of Myeloproliferative Neoplasms
ESH eLearning, Martin Griesshammer, 348292
Russian recommendations to manage pregnancy in CML
ESH eLearning, Ekaterina Chelysheva, 348291
Pregnancy and TKI
ESH eLearning, Elisabetta Abruzzese, 348290
Introduction
ESH eLearning, Jane APPERLEY, 348289
Discussion
ESH eLearning, Faculty / Presenters, 348288
Infections in MPN - patients survey
ESH eLearning, Florian Heidel, 348287
COVID-19 and CML
ESH eLearning, Delphine Rea, 348286
Introduction
ESH eLearning, Ruben Mesa, 348285
Discussion
ESH eLearning, Faculty / Presenters, 348284
No
ESH eLearning, Claire Harrison, 348283
Yes
ESH eLearning, Florian Heidel, 348282
Introduction
ESH eLearning, Ruben Mesa, 348281
Panel discussion
ESH eLearning, Faculty / Presenters, 348280
Case-based lecture: Vascular risk assessment in MPN
ESH eLearning, Emmanuel Messas, 348279

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings